Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy

Hongyan Yuan; Levy Kopelovich; Yuzhi Yin; Jin Lu; Robert I. Glazer

doi:10.18632/oncotarget.26161

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Errata:

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy

PDF | How to cite

Oncotarget. 2018; 9:33866-33866. https://doi.org/10.18632/oncotarget.26161

Metrics: PDF 1434 views | ?

Hongyan Yuan¹, Levy Kopelovich², Yuzhi Yin^1,3, Jin Lu¹ and Robert I. Glazer¹

¹ Department of Oncology, Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, Washington, DC
² Chemoprevention Branch, National Cancer Institute, Bethesda, MD
³ Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD

Published: September 18, 2018

This article has been corrected: During production, the ending page number for this article was listed incorrectly. The page count has now been adjusted to show the proper pagination.

Original article: Oncotarget. 2012; 3:345-356. DOI: https://doi.org/10.18632/oncotarget.457.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26161

Publication Alerts

Post-Publication Promotion

Publication Discount

Errata:

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy